Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Kewaunee Scientific (KEQU) over the last 16 years, with Q4 2025 value amounting to $1.6 million.

  • Kewaunee Scientific's Capital Expenditures rose 12986.82% to $1.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $3.5 million, marking a year-over-year increase of 4683.23%. This contributed to the annual value of $2.2 million for FY2025, which is 5046.88% down from last year.
  • Kewaunee Scientific's Capital Expenditures amounted to $1.6 million in Q4 2025, which was up 12986.82% from $771000.0 recorded in Q3 2025.
  • Over the past 5 years, Kewaunee Scientific's Capital Expenditures peaked at $2.6 million during Q2 2023, and registered a low of $278000.0 during Q3 2024.
  • Its 5-year average for Capital Expenditures is $802050.0, with a median of $647500.0 in 2021.
  • Its Capital Expenditures has fluctuated over the past 5 years, first skyrocketed by 32410.26% in 2023, then tumbled by 8319.23% in 2024.
  • Quarter analysis of 5 years shows Kewaunee Scientific's Capital Expenditures stood at $446000.0 in 2021, then increased by 18.61% to $529000.0 in 2022, then surged by 139.13% to $1.3 million in 2023, then plummeted by 46.01% to $683000.0 in 2024, then soared by 129.87% to $1.6 million in 2025.
  • Its last three reported values are $1.6 million in Q4 2025, $771000.0 for Q3 2025, and $516000.0 during Q2 2025.